Saving changes...

Done

Error

VCS 2020: COMBINING ZOLEDRONATE WITH RADIATION THERAPY TO ENHANCE THE TREATMENT OF OSTEOINVASIVE FELINE ORAL SQUAMOUS CELL CARCINOMA

VCS 2020: COMBINING ZOLEDRONATE WITH RADIATION THERAPY TO ENHANCE THE TREATMENT OF OSTEOINVASIVE FELINE ORAL SQUAMOUS CELL CARCINOMA

VCS 2020: COMBINING ZOLEDRONATE WITH RADIATION THERAPY TO ENHANCE THE TREATMENT OF OSTEOINVASIVE FELINE ORAL SQUAMOUS CELL CARCINOMA

Alycen Lundberg
Alycen Lundberg
on behalf of Missouri Veterinary Medical Association

$FREE $ FREE $ FREE

$ FREE $ FREE $ FREE
$ 10.00 $ 10.00 $ 10.00
Normal Price: FREE $10.00

Review:

Launch date: 22 Nov 2020
Expiry Date:

Last updated: 27 Jan 2021

Reference: 196372

Maximum Attendees:

Places Left: 0

This course is no longer available

Exam is embedded in the course
No preview available
No Exam Available

Latest User Comments

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

You have null days left.

Description

Zoledronate can directly affect osteoblastic and osteoclastic activity
Exam offered and MVMA CE certificate issued following presentation.

Objectives

Zoledronate can directly affect osteoblastic and osteoclastic activity
Alycen Lundberg

Author Information Play Video Bio

Alycen Lundberg
on behalf of Missouri Veterinary Medical Association

Alycen Lundberg DVM, DACVIM (Oncology)

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

  • Missouri Veterinary Medical Association
  • 0.25 Hours -
    Exam Attempts: 3
    -
    Exam Pass Rate: 60

Faculty and Disclosures

Additional Contributors

Conflicts Declared

Conflicts of Interest declaration by Author:

null

User Reviews (0)

Go Back

Loading...


Saving changes...

Done

Error